About
MultiOmic develops an AI-enabled precision medicine platform targeting cardio-renal-metabolic diseases, focusing initially on chronic kidney disease by integrating multi-omics and longitudinal patient data to identify molecular disease drivers and create targeted therapeutics.
Explore MultiOmic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.